Statistics
Publications
45
Citations
5.8K
H-Index
32
Active since
1993
Daniel P. Sutherlin is an author at Xenon Pharmaceuticals (Canada) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1993–2021
45
45
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson, Jane Fridlyand, Yibing Yan et al. · Nature · 2012 · 1.1K citations
Medicine, Cancer Biology, Oncology +16
A Unified Model for Apical Caspase Activation
Kelly M. Boatright, Martin Renatus, Fiona L. Scott et al. · Molecular Cell · 2003 · 945 citations · Full text
GDC-0449—A potent inhibitor of the hedgehog pathway
Kirk Robarge, Shirley A. Brunton, Georgette M. Castanedo et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 387 citations · Full text
Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist
Shivani Ahuja, Susmith Mukund, Lunbin Deng et al. · Science · 2015 · 327 citations · Full text
1–5 of 45